SAMPLE TECHNOLOGIES

Impact Diagnostics, from UMB, is pursuing the commercialization of a novel diagnostic test for HIV that is twenty-five times more sensitive than the currently available tests. The increased sensitivity of the test makes it a better option for screening blood donations, organ donors, and patient surveillance on highly active antiretroviral therapy (HAART).

Hyperspectral Imaging Technology. This technology from UMBC enables hyperspectral image analysis in real time. Hyperspectral imaging has a variety of potential applications from medical imaging and military target identification to detecting environmental contaminants, but its current use is limited because of the processing time required for analysis. ACTiVATE® is analyzing a technology that overcomes this limitation.

I-Cube is developing a commercialization plan for advanced semiconductor materials. One application of the materials is the fabrication of solar cells that can generate power more efficiently than those currently available – even on cloudy days. The technology can also be used to fabricate lower power integrated circuits that can be used in everyday products resulting in longer battery life.

Active Bodywear is a product concept from NASA Goddard that is based on a novel technology that could have a variety of uses in functional clothing. The technology efficiently distributes body heat from a warm to a cold region of the body, e.g., under the arms to the hands. The initial market focus will be on sportswear.

TraxIon Technologies is commercializing a novel technology from JHU that will be useful for identifying new drug candidates for diseases such as Alzheimer's disease, heart disease, diabetes, and other diseases attributed to problems with membrane ion channels. TraxIon will market cell lines, an ion trafficking assay, and a protein chip that will help pharmaceutical companies identify new drug candidates.

Foligo Therapeutics is developing new cancer therapeutics using antisense technology that targets the folate receptor, which is present in many cancer types but not expressed in normal cells. This approach might be especially useful for treating ovarian cancer.